Tag: phase
Sensorion announces that the primary endpoint of the Phase 2a clinical study of SENS-401 in the preservation of residual hearing has been achieved – 03/11/2024 at 07:30
Sensorion announces that the primary endpoint of the Phase 2a clinical study of SENS-401 in the preservation of residual hearing has been achieved•The presence of SENS-401 is confirmed in the…
Inventiva announces the resumption of screening in the Phase III clinical study, NATiV3, evaluating lanifibranor in NASH – 03/07/2024 at 10:00 p.m.
Daix (France), Long Island City (New York, United States), March 7, 2024 – Inventiva (Euronext Paris and Nasdaq: IVA) (the “Company”), a biopharmaceutical company specializing in the clinical development of…
MaaT Pharma: end of phase 2 trial recruitment – 03/05/2024 at 2:09 p.m.
(CercleFinance.com) – MaaT Pharma announced on Tuesday that it had completed the recruitment of patients in its Phase 2a clinical trial evaluating MaaT013, its most advanced drug candidate, in melanoma.…
GTA 6 enters its final phase of development, and developers return to the office – Grand Theft Auto VI
Three days ago we offered with a magnificent band, GТА 6 will soon enter its latest development phase, се that еѕtоjоurѕ a good ѕіgnе, рuіѕquе lе рrоjеt аvаnсе bіеn аnd…
Pharnext advances analysis of data from the pivotal Phase III study of PXT3003 in Charcot-Marie-Tooth disease type 1A
By Hector Chaunu Published on 02/28/2024 at 9:00 a.m. Photo credit © ChaunuPictures (Boursier.com) — Pharnext SCA,…
Sanofi: positive phase II data in urticaria – 02/26/2024 at 07:08
(CercleFinance.com) – Sanofi announces the results of the RILECSU phase II study showing that its rilzabrutinib can quickly reduce the severity of itching caused by chronic spontaneous urticaria and significantly…
Sanofi: Positive phase II data in urticaria
Receive the value of the day for free every morning The data collected is essential for this processing and is intended for the relevant services of BFM Bourse and, where…
Sanofi: positive phase II data in urticaria
(CercleFinance.com) – Sanofi announces the results of the RILECSU phase II study showing that its rilzabrutinib can quickly reduce the severity of itching caused by chronic spontaneous urticaria and significantly…
Sanofi Presents Phase II Results of Rilzabrutinib at AAAAI Congress
By Alexandra Saintpierre Published on 02/25/2024 at 6:18 p.m. Photo credit © Sanofi (Boursier.com) — Breaking data presented…
Press release: Phase II results show that rilzabrutinib can quickly reduce the severity of itching caused by chronic spontaneous urticaria and significantly improve disease activity in adults – 02/24/2024 at 3:51 p.m.
Phase II Results Show Rilzabrutinib Rapidly Reduces Severity of Itching Caused by Chronic Spontaneous Urticaria and Significantly Improves Disease Activity in Adults Breaking data presented at the 2024 AAAAI Congress…
The Berlinale in its terminal phase, with a procession of characters at the end of their lives, the dead and ghosts
Lissy (Corinna Harfouch) and Tom (Lars Eidinger) in “Sterben”, by Matthias Glasner. JAKUB BEJNAROWICZ/PORT AU PRINCE/SCHWARZWEISS/SENATOR While the 74e edition of the Berlinale is coming to an end – the…
WoW SoD: What is the maximum rank to reach in PvP in phase 2? – World of Warcraft Classic
The РvР іnсаrnе another way to play Wоrld оf Wаrсrаft, аnd реrmеt оbtеnіr еѕ соmреnѕеѕ ѕрéс It can even be used in РvЕ. Рluѕ еnсоrе, еn рluѕ of the рlаіѕіr…